Popular Articles
Burdock Root

U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) approved ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor. ONGLYZA is indicated as an adjunct to diet and exercise to improve blood sugar (glycemic) control in adults for the treatment of type 2 diabetes mellitus. ONGLYZA once daily can be used in combination with commonly prescribed oral anti-diabetic medications - metformin, sulfonylureas or thiazolidinediones (TZD) - or as a monotherapy to significantly reduce glycosylated hemoglobin (A1C) levels. ONGLYZA should not be used for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis (high levels of certain acids, known as ketones, in the blood or urine). ONGLYZA has not been studied in combination with insulin.
generic viagra online
RCN Calls For EU Agreement On Sharps Injuries To Be Implemented Quickly
The Royal College of Nursing welcomed the signing of a joint agreement by European Federation of Public Service Unions (EPSU) and the European Hospital and Healthcare Employers Association (HOSPEEM). This is an EU-wide agreement which the RCN has played a key role in bringing about to prevent one million medical sharps injuries per year. Dr Peter Carter, Chief Executive of the Royal College of Nursing (RCN), said:
News of the day
RDAA Survey Shows Widespread Support For Medicare Loading For Rural And Remote Doctors
Over 80% of rural and remote doctors recently surveyed by the Rural Doctors Association of Australia (RDAA) believe adding a significant rural and remote loading on Medicare items would assist in recruiting and retaining doctors in their communities.
Cardiovascular

Smoking, High Blood Pressure And Diabetes In Mid-life Can Lead To Dementia

Middle aged people who smoke, have high blood pressure or diabetes are far more likely to develop dementia in later life, suggests research published ahead of print in the Journal of Neurology, Neurosurgery and Psychiatry. People should consider modifying their lifestyle in mid-life to avoid developing dementia, claims the US research. Dementia is a growing public health problem affecting older people in developed countries. In the US, where the research took place, estimates show that one in six people older than 70 have dementia. Estimates are that the number of people with dementia will grow threefold by 2050, compared with 2000. Previous studies have shown that the presence of cardiovascular risk factors including high blood pressure, diabetes, obesity and smoking increase the risk of developing subsequent dementia, but have often failed to show the relationship. Researchers from the universities of Minnesota, North Carolina and John Hopkins and the University of Mississippi Medical Center studied more than 11,000 people aged 46-70 who were participants in the Atherosclerosis Risk in Communities (ARIC) study in 1990-92. People underwent a physical examination and cognitive testing at that time and they were followed up until 2004 to see how many were hospitalised with dementia. After following their progress, the researchers identified 203 cases of hospitalisation with dementia. Smoking, high blood pressure and diabetes were all strongly associated with dementia in white participants and African-Americans. The results showed that rates of hospitalisation with dementia increased exponentially with age in men and women and in different ethnic backgrounds. Overall, African-Americans had a two and a half times higher rate of hospitalisation than white people and African-American women in particular had the highest rates of all. Current smokers were 70% more likely than those who had never smoked to develop dementia, people with high blood pressure were 60% more likely than those without high blood pressure, and people with diabetes were more than twice as likely than those without diabetes to develop it. No association was found between people who were obese/overweight and dementia in later life. The authors say the results suggest that smoking cessation and prevention or control of high blood pressure and diabetes starting in midlife may have the added benefit of decreasing dementia hospitalisation risk. They conclude: "Our results emphasise the importance of early lifestyle modification and risk factor treatment to prevent dementia." "Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study." J Neurol Neurosurg Psychiatry2009; doi 10.1136/jnnp.2009.176818 Journal Of Neurology, Neurosurgery & Psychiatry


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):